Recurrent Endometrial Cancer

Known as: Recurrent Corpus Uteri Cancer, carcinoma of the endometrium, recurrent, recurrent cancer of the endometrium 
Reemerging uterine corpus carcinoma after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Dysregulation of phosphatase and tensin homolog (PTEN) and the gene that encodes the p110α catalytic subunit of… (More)
Is this relevant?
2010
2010
OBJECTIVE To determine the relative effect and quantify the impact of multiple prognostic variables on median overall survival… (More)
Is this relevant?
Review
2009
Review
2009
Endometrial carcinoma is frequently diagnosed at an early stage, at which point it is usually surgically curable. Some less… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE To study the effect of trastuzumab in patients with progressive or recurrent metastatic endometrial carcinoma shown by… (More)
Is this relevant?
Review
2007
Review
2007
Endometrial cancer is one of the most common gynecologic malignancies. In patients with advanced or recurrent endometrial cancer… (More)
Is this relevant?
2006
2006
OBJECTIVE To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with… (More)
Is this relevant?
2005
2005
BACKGROUND Sarcoidosis is a multisystem disease and can be confused with benign or malignant tumors. In patients with recurrent… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE To evaluate the efficacy of carboplatin plus paclitaxel in primarily advanced or recurrent endometrial cancers… (More)
Is this relevant?
2000
2000
OBJECTIVES The aims of this study were to determine the overall survival (OS) and local control (LC) achieved in patients… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE Progestins have definite activity against advanced or recurrent endometrial carcinoma. Both parenteral and oral… (More)
Is this relevant?